Faslodex Specific Clinical Experience Investigation

Study identifier:D6997C00008

ClinicalTrials.gov identifier:NCT01501266

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Faslodex Specific Clinical Experience Investigation for long-term use

Medical condition

Breast Cancer

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

Female

Actual Enrollment

660

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Feb 2012
Primary Completion Date: 01 Jan 2015
Study Completion Date: 01 Jan 2015

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria